PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Detroit researchers receive Department of Defense grant to assist in discovering new treatments for ovarian cancer

Detroit researchers receive Department of Defense grant to assist in discovering new treatments for ovarian cancer
2024-07-08
(Press-News.org) DETROIT — Gen Sheng Wu, Ph.D., professor of oncology in the Wayne State University School of Medicine and the Barbara Ann Karmanos Cancer Institute, recently received a grant from the U.S. Department of Defense’s Congressionally Directed Medical Research Programs.

This four-year, $924,000 grant will benefit Wu’s study, “Targeting Dual-Specificity Phosphatase 1 in Platinum Resistance in Ovarian Cancer,” which aims to discover improved treatments for ovarian cancer.

“Ovarian cancer is one of the deadliest diseases,” said Wu. “It’s difficult to diagnose early and most cases are only found in the late stages. The late stage survival rate is approximately 30%. After surgery, chemotherapy is the other primary treatment; however, patients develop a resistance to this treatment very quickly. It’s a major problem with ovarian cancer and it’s our major challenge in the field.”

The overarching challenge that this research will address is the elimination of drug-resistant ovarian cancer cells using new treatment regimens. Specifically, Wu and his research team have identified a resistance mechanism that involves a protein called dual-specificity phosphatase 1 (DUSP1).

Wu believes this could be an important step in addressing ovarian cancer because it has the potential to improve the efficacy of platinum-based therapies. Platinum-based therapies are the standard first-line chemotherapy for most patients with ovarian cancer. However, almost all patients receiving platinum eventually relapse and die from metastatic disease, mainly due to primary and acquired resistance to the treatment.

“With this grant, we will follow up  findings that phosphatases can remove the phosphate group and thus shut down MAPK signaling,” said Wu. “Based on this mechanism, we are studying how this reaction works and how implementing it may increase survival and remission rates.”

“Ovarian cancer is the fifth leading cause of cancer-related deaths among women, and this important funding will help Dr. Wu and his research team to help address this critical challenge,” said Ezemenari Obasi, Ph.D., vice president for research at Wayne State University. “Dr. Wu’s work has the potential to make a lifesaving difference for patients in our community and beyond.”

The award number for this Department of Defense Ovarian Cancer Research Program grant is HT9425-24-1-0694.

# # #

About Wayne State University

Wayne State University is one of the nation’s pre-eminent public research universities in an urban setting. Through its multidisciplinary approach to research and education, and its ongoing collaboration with government, industry and other institutions, the university seeks to enhance economic growth and improve the quality of life in the city of Detroit, state of Michigan and throughout the world. For more information about research at Wayne State University, visit research.wayne.edu.

Wayne State University’s research efforts are dedicated to a prosperity agenda that betters the lives of our students, supports our faculty in pushing the boundaries of knowledge and innovation further, and strengthens the bonds that interconnect Wayne State and our community. To learn more about Wayne State University’s prosperity agenda, visit president.wayne.edu/prosperity-agenda.

END


[Attachments] See images for this press release:
Detroit researchers receive Department of Defense grant to assist in discovering new treatments for ovarian cancer Detroit researchers receive Department of Defense grant to assist in discovering new treatments for ovarian cancer 2 Detroit researchers receive Department of Defense grant to assist in discovering new treatments for ovarian cancer 3

ELSE PRESS RELEASES FROM THIS DATE:

Acupuncture reduces methadone dose and opioid cravings in patients undergoing methadone maintenance therapy

2024-07-08
Embargoed for release until 5:00 p.m. ET on Monday 8 July 2024     Annals of Internal Medicine Tip Sheet      @Annalsofim     Below please find summaries of new articles that will be published in the next issue of Annals of Internal Medicine. The summaries are not intended to substitute for the full articles as a source of information. This information is under strict embargo and by taking it into possession, media representatives are committing to the terms of ...

Novel compound offers improved defense against fentanyl overdoses

2024-07-08
Scientists at the University of Florida have identified a novel compound aimed at improving the treatment of opioid overdoses, which claimed the lives of more than 81,000 Americans last year. The discovery could combat the devastating epidemic of opioid-related deaths, driven predominantly by the proliferation of fentanyl. The highly potent synthetic opioid is a pain reliever and among the nation’s most abused substances. “Fentanyl is driving the need to find better treatments for opioid overdoses,” said Jay McLaughlin, Ph.D., a professor of pharmacodynamics in the UF College of Pharmacy. “Every opioid death is preventable, highlighting ...

NIH awards Wake Forest University School of Medicine $27 million to study vascular health and its impact on cognition

2024-07-08
WINSTON-SALEM, N.C. – July 8, 2024 – Researchers at Wake Forest University School of Medicine have been awarded a five-year, $27 million grant from the National Institute on Aging (NIA), part of the National Institutes of Health (NIH), to renew funding for MESA-MIND, an ancillary study to the Multi-Ethnic Study of Atherosclerosis (MESA). In 2018, researchers at Wake Forest University School of Medicine received more than $18 million from the NIA to launch MESA-MIND to study the connections between heart health and brain health. “In MESA-MIND, we are studying how heart health contributes to brain health in diverse groups of people,” said Timothy Hughes, Ph.D., ...

College of Public Health receives NIH grant to pilot AI chatbot for African Americans with depression

2024-07-08
As a leader in innovative health solutions, George Mason University’s College of Public Health received a National Institutes of Health (NIH) AIM-AHEAD program grant to pilot an artificial intelligence (AI) chatbot for Black and African Americans with depression. Health Informatics Professor Farrokh Alemi will enhance his first-of-its-kind, evidence-based artificial intelligence tool to address the medication needs of African Americans with depression.   The existing AI tool recommends antidepressants for 16,775 general-population patient subgroups, each representing a unique combination of medical history. For each of ...

RCMAR Annual Meeting promotes mentorship and research on aging

2024-07-08
The latest Annual Meeting convened by the Resource Centers for Minority Aging Research (RCMAR) National Coordinating Center, held in Arlington, Virginia, from June 26 to 28, centered on the theme of transforming diverse aging research through inspiring and mentoring scientists. Current and former RCMAR scientists presented research findings from completed pilot studies and progress updates for ongoing research. The meeting included several professional development sessions for the scientists and members of RCMAR ...

Exploring distress experiences of patients with sickle cell disease

Exploring distress experiences of patients with sickle cell disease
2024-07-08
COLUMBUS, Ohio – While distress is well-documented in patients with sickle cell disease, sources of distress and how patients manage distress have not been well explored. “Our study found that the most profound source of distress for patient with sickle cell disease in a home visit program was anticipating and going to acute care centers to manage their acute pain,” said senior study author Maryanna Klatt, PhD, director of the Center for Integrative Health at The Ohio State University Wexner Medical Center. Study findings are published ...

Super-resolution machining of single crystalline sapphire by GHz burst mode femtosecond laser-induced plasma assisted ablation

Super-resolution machining of single crystalline sapphire by GHz burst mode femtosecond laser-induced plasma assisted ablation
2024-07-08
A new publication from Opto-Electronic Advances; DOI  10.29026/oea.2024.240029 , discusses super-resolution machining of single crystalline sapphire by GHz burst mode femtosecond laser-induced plasma assisted ablation.   GHz burst-mode femtosecond (fs) laser, which emits a series of pulse trains (burst pulse) with extremely short intervals of several hundred ps, offers distinct characteristics in materials processing as compared with conventional fs laser (single-pulse mode). The authors of this article have demonstrated that the GHz burst mode fs laser greatly improves ablation efficiency, quality and speed. GHz burst mode fs laser was further applied ...

Boosting UV light absorption in 2D semiconductor with quantum dot hybrids for enhanced light emission

Boosting UV light absorption in 2D semiconductor with quantum dot hybrids for enhanced light emission
2024-07-08
A new publication from Opto-Electronic Advances; DOI  10.29026/oes.2024.240002 , discusses boosting UV Light Absorption in 2D Semiconductor with quantum dot hybrids for enhanced light emission. Two-dimensional (2D) transition metal dichalcogenides (TMDs) have emerged as a promising class of materials due to their remarkable properties. These materials, such as monolayer tungsten disulfide (1L-WS2), are just a few atoms thick, yet they possess intriguing electronic and optical characteristics that make them highly attractive for various applications, from flexible electronics ...

The forbidden propagation of hyperbolic phonon polaritons and applications in near-field energy transport

The forbidden propagation of hyperbolic phonon polaritons and applications in near-field energy transport
2024-07-08
A new publication from Opto-Electronic Advances; DOI  10.29026/oes.2024.230053 , discusses forbidden propagation of hyperbolic phonon polaritons and applications in near-field energy transport.   Manipulating photons on the nanoscale to develop integrated and miniaturized optoelectronic devices as well as photonic chips has been a strong pursuit of the nanophotonics community. Among them, phonon polaritons supported by two-dimensional layered van der Waals (vdW) materials, which have emerged in recent years, have attracted much attention by virtue of their ultra-long lifetimes, ultr-low losses, and strong confinement capabilities, ...

Researchers find common immune system mechanism between pregnancy, cancer

Researchers find common immune system mechanism between pregnancy, cancer
2024-07-08
For more information, contact: Nicole Fawcett, nfawcett@umich.edu 734-764-2220   For immediate release   ANN ARBOR, Michigan — To understand why some cancers successfully circumvent the immune system to grow unchecked, researchers turned to pregnancy. “In pregnancy, the immune system does not reject the growing fetus, so we know there must be mechanisms active in the placenta. In cancer, it’s the same thing: the growing tumor is not rejected by the immune system. It means the cancer cells have developed strategies to suppress immune rejection, same as in pregnancy,” said Weiping ...

LAST 30 PRESS RELEASES:

Link found between kneecap shape and debilitating joint disease

Generative AI tools like Pix2Pix–BicycleGAN are revolutionizing landscape design by enhancing masterplan generation and rendering

Expanding APAC presence, Insilico Medicine seals strategic collaboration on AI-driven mash therapy development with Korean Biotech Therasid Bioscience

When it comes to butterflies, people prefer pretty ones. That’s a problem for scientists.

UBC Okanagan study raises concerns about partner violence in queer relationships

Human-infecting parasite produces sterile soldiers like ants and termites

The unintended consequences of success against malaria

Taco-shaped arthropod from Royal Ontario Museum’s Burgess Shale fossils gives new insights into the history of the first mandibulates

Butterflies accumulate enough static electricity to attract pollen without contact, new research finds

Eyes for Love: Searching for light and a mate in the deep, dark sea, male dragonfishes grow larger eyes than the females they seek

PNNL scientists tap nation’s fastest computers to explore critical science questions

Peri-operative care of transgender and gender-diverse individuals: new guidance for clinicians and departments published

Clinical psychologist’s book addresses largely ignored problem: social anxiety

Researchers leveraging AI to train (robotic) dogs to respond to their masters

Drawing water from dry air

Combining trapped atoms and photonics for new quantum devices

A new way to make element 116 opens the door to heavier atoms

New genetic tool could identify drug targets for diseases associated with metabolic dysfunction

Plant Biologist Siobhan Brady named HHMI Investigator

Long-acting injectable cabotegravir for HIV prevention is safe in pregnancy

Large language models don’t behave like people, even though we may expect them to

NREL researchers highlight opportunities for manufacturing perovskite solar panels with a long-term vision

Top Medicare advantage plans less available in disadvantaged areas

Better carbon storage better carbon storage with stacked geology with stacked geology

Sharp temperature reduction for quantum dots in polymer by highly efficient heat dissipation pathways

UAF researcher creates way to detect elusive volcanic vibrations

Lissajous pattern multi-pass cell: Enhancing high sensitivity and simultaneous dual-gas LITES sensing

Asexual reproduction usually leads to a lack of genetic diversity. Not for these ants.

Mini lungs make major COVID-19 discoveries possible

Exploratory analysis associates HIV drug abacavir with elevated cardiovascular disease risk in large global trial

[Press-News.org] Detroit researchers receive Department of Defense grant to assist in discovering new treatments for ovarian cancer